GO
Loading...

Enter multiple symbols separated by commas

Stocks GlaxoSmithKline PLC

More

  • July 21- Novavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults. Vaccines being developed by Bavarian Nordic, GlaxoSmithKline and Johnson& Johnson have entered mid-stage studies. Gaithersburg, Maryland- based Novavax's shares have risen more than...

  • Tekmira Pharmaceuticals Corp. said last month that an experimental Ebola treatment that it was developing would probably fail in a clinical trial. The Canadian company says it will focus on experimental treatments for the hepatitis B virus and will change its name to Arbutus Biopharma Corp.. Other companies in the field included NewLink Genetics Corp.,...

  • DUBLIN, July 16- Britain's Immunocore completed Europe's largest ever financing round by a private life sciences company on Thursday, raising $320 million from investors including Eli Lilly& Co, Malin and Woodford Investment Management. The investment by some of the healthcare sector's "most highly regarded international institutions" is another...

  • MUMBAI, July 16- India has extended price caps to an additional 39 drugs ranging from commonly used diabetes treatments to antibiotics, in the government's latest effort to improve the affordability of medicines. Wide-ranging price cuts over the past year have hit several drugmakers in India and have been opposed by many in the industry, who say drug prices in...

  • LONDON, July 14- It's a showpiece drug that has the potential to end a disease that kills half a million African children a year. Backed by billionaire philanthropist Bill Gates and developed by GlaxoSmithKline, the vaccine-- called RTS, S or Mosquirix-- is being assessed by regulators and global health authorities. But it's a very complicated vaccine, so the...

  • BEIJING, July 9- Chinese authorities have detained about half a dozen former employees of Tencent Holdings Ltd, the country's biggest social network and online media company, as part of a graft investigation following an internal company probe, Tencent said late on Thursday. Amid a continuing crackdown on corruption by Chinese President Xi Jinping, Tencent...

  • LONDON, July 2- China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai- based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient. The collaboration between GSK's HIV unit ViiV Healthcare and Desano marks an improvement in the business climate for the...

  • Pfizer Inc, the largest U.S. drugmaker, for example reported more than $234.2 million in research payments and another $53.3 million in general payments. John Diliberti, a pediatric geneticist from Illinois, collected nearly $447,000 from Pfizer in consulting fees last year, the biggest single payment to an individual doctor by the drugmaker.

  • Philip Morris International Inc has hired more than 400 scientists and technical staff at its research facility in Neuchatel, Switzerland, including toxicologists, chemists, biologists, biostatisticians and regulatory affairs experts. Altria Group Inc, makers of Marlboro, has recruited dozens of scientific and healthcare experts, as have independent...

  • Early movers: CI, WMB, PFE, ALL, AAPL & more Monday, 22 Jun 2015 | 7:47 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE).

    Some of the names on the move ahead of the open.

  • LONDON, June 22- GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis. The British drugmaker said on Monday that the total consideration for the sale of its Nimenrix and Mencevax products to Pfizer's Irish unit, including some deferred payments, was...

  • LONDON/ BEIJING, June 18- A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc. Peter Humphrey and his American wife Yu Yingzeng returned to Britain on Wednesday evening after...

  • ZURICH, June 18- Novartis AG said on Thursday it expects to increase its profit margin this year as it restructures its drug portfolio and cuts costs, as well as generate cash for a higher dividend and smaller, strategic acquisitions. Novartis, the world's biggest supplier of prescription drugs by sales, is briefing investors about prospects at its research...

  • *Guinea trial last chance to show vaccine efficacy. LONDON, June 17- Drugmakers' plans to conduct vast clinical trials to test and hopefully validate the first Ebola vaccines have been thwarted by success in beating back the deadly epidemic in West Africa. The haemorrhagic Ebola virus has killed more than 11,000 people in Guinea, Sierra Leone and Liberia in an...

  • MERS: Why is there still no vaccine? Monday, 15 Jun 2015 | 8:42 PM ET
    A South Korean medical worker (L) wearing protective gear handles a sample tube from a man (C) suspected of carrying the MERS virus in Seoul, South Korea.

    Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine.

  • Biggest biotech IPO ever—and the CEO is 29! Thursday, 11 Jun 2015 | 6:23 PM ET
    Vivek Ramaswamy, CEO, Axovant Sciences

    Jim Cramer sits down with Axovant Sciences CEO Vivek Ramaswamy in the wake of its massive IPO on Thursday.

  • NEW YORK, June 11- A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits. Plaintiff Rachel Robinson claimed in her 2011 lawsuit that Pfizer failed to warn that using Zoloft during pregnancy...

  • China graft probes a tough tonic as pharma margins bounce Wednesday, 10 Jun 2015 | 5:00 PM ET

    Faster growth in China is good news for local and global firms chasing a medicine bill estimated by IMS Health to hit $185 billion by 2018, but who have taken a hit from a series of bribery probes that led to a $500 million fine against British drugmaker GlaxoSmithKline PLC last year. "Sales departments did slow down activities in China and have taken their time to...

  • SHANGHAI, June 9- A British corporate investigator linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC is to be released early from a 2 1/ 2- year sentence in a Chinese jail, a source close to his family said on Tuesday. The case was intertwined with an investigation of GSK in China which rocked the country's pharmaceutical market and led...

  • Early movers: MDT, PVH, DG, SHLD, AAPL & more Tuesday, 2 Jun 2015 | 7:48 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.